According to the results of previous studies, SBF2-AS1 can be used as a molecular sponge of miRNA to promote the progression of many kinds of tumors, such as diffuse large B-cell lymphoma [26], hepatocellular carcinoma [27], non-small cell lung cancer [28], and cervical cancer [29]. Here, SBF2 is linked to hepatocellular carcinoma.